Everus (ECG) Competitors $38.77 +0.60 (+1.58%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$37.88 -0.90 (-2.31%) As of 04/17/2025 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ECG vs. TMHC, IBP, ROAD, IESC, GRBK, DFH, BBU, CCS, LGIH, and SDHCShould you be buying Everus stock or one of its competitors? The main competitors of Everus include Taylor Morrison Home (TMHC), Installed Building Products (IBP), Construction Partners (ROAD), IES (IESC), Green Brick Partners (GRBK), Dream Finders Homes (DFH), Brookfield Business Partners (BBU), Century Communities (CCS), LGI Homes (LGIH), and Smith Douglas Homes (SDHC). These companies are all part of the "construction" industry. Everus vs. Taylor Morrison Home Installed Building Products Construction Partners IES Green Brick Partners Dream Finders Homes Brookfield Business Partners Century Communities LGI Homes Smith Douglas Homes Taylor Morrison Home (NYSE:TMHC) and Everus (NYSE:ECG) are both construction companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, community ranking, analyst recommendations, institutional ownership and risk. Do institutionals and insiders hold more shares of TMHC or ECG? 95.2% of Taylor Morrison Home shares are held by institutional investors. 3.5% of Taylor Morrison Home shares are held by company insiders. Comparatively, 0.2% of Everus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in TMHC or ECG? Taylor Morrison Home received 475 more outperform votes than Everus when rated by MarketBeat users. However, 87.50% of users gave Everus an outperform vote while only 59.51% of users gave Taylor Morrison Home an outperform vote. CompanyUnderperformOutperformTaylor Morrison HomeOutperform Votes48259.51% Underperform Votes32840.49% EverusOutperform Votes787.50% Underperform Votes112.50% Do analysts rate TMHC or ECG? Taylor Morrison Home presently has a consensus price target of $78.00, suggesting a potential upside of 38.20%. Everus has a consensus price target of $63.33, suggesting a potential upside of 63.35%. Given Everus' higher probable upside, analysts plainly believe Everus is more favorable than Taylor Morrison Home.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Taylor Morrison Home 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Everus 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor TMHC or ECG? In the previous week, Everus had 27 more articles in the media than Taylor Morrison Home. MarketBeat recorded 37 mentions for Everus and 10 mentions for Taylor Morrison Home. Taylor Morrison Home's average media sentiment score of 0.99 beat Everus' score of 0.15 indicating that Taylor Morrison Home is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Taylor Morrison Home 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Everus 5 Very Positive mention(s) 9 Positive mention(s) 21 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Is TMHC or ECG more profitable? Taylor Morrison Home has a net margin of 10.81% compared to Everus' net margin of 0.00%. Taylor Morrison Home's return on equity of 16.50% beat Everus' return on equity.Company Net Margins Return on Equity Return on Assets Taylor Morrison Home10.81% 16.50% 10.16% Everus N/A N/A N/A Which has preferable valuation and earnings, TMHC or ECG? Taylor Morrison Home has higher revenue and earnings than Everus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTaylor Morrison Home$8.17B0.70$883.31M$8.286.82Everus$2.85B0.69$143.42MN/AN/A SummaryTaylor Morrison Home beats Everus on 12 of the 15 factors compared between the two stocks. Get Everus News Delivered to You Automatically Sign up to receive the latest news and ratings for ECG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ECG vs. The Competition Export to ExcelMetricEverusOperative builders IndustryConstruction SectorNYSE ExchangeMarket Cap$1.98B$6.31B$7.87B$18.41BDividend YieldN/A1.66%2.10%4.20%P/E RatioN/A6.5815.0031.07Price / Sales0.690.7070.4226.55Price / CashN/A7.6421.4017.53Price / BookN/A1.333.964.30Net Income$143.42M$854.81M$535.55M$1.02B7 Day Performance0.84%0.32%0.39%1.42%1 Month Performance2.73%-10.43%53.39%-7.33%1 Year PerformanceN/A-21.07%71.33%2.27% Everus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ECGEverus2.2737 of 5 stars$38.77+1.6%$63.33+63.3%N/A$1.98B$2.85B0.007,600News CoverageTMHCTaylor Morrison Home4.4516 of 5 stars$55.86+0.1%$79.57+42.4%+4.5%$5.68B$8.17B6.753,000Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsIBPInstalled Building Products4.5935 of 5 stars$168.21-0.2%$216.09+28.5%-29.5%$4.67B$2.94B18.6910,300Positive NewsROADConstruction Partners3.739 of 5 stars$79.63-0.9%$92.00+15.5%+50.9%$4.45B$1.99B74.423,790Insider TradePositive NewsIESCIES2.7928 of 5 stars$188.78+5.0%N/A+57.9%$3.78B$3.00B17.588,080News CoveragePositive NewsGRBKGreen Brick Partners3.2059 of 5 stars$56.85+1.9%$74.00+30.2%+7.3%$2.53B$2.10B7.38550DFHDream Finders Homes2.8872 of 5 stars$21.84+1.0%$30.17+38.1%-37.3%$2.04B$4.45B7.141,210Gap UpBBUBrookfield Business Partners4.143 of 5 stars$20.60+2.0%$32.33+57.0%+5.4%$1.87B$40.62B-42.0472,000Positive NewsCCSCentury Communities4.6682 of 5 stars$59.33+0.2%$103.00+73.6%-24.4%$1.82B$4.40B5.701,540Upcoming EarningsPositive NewsLGIHLGI Homes3.4219 of 5 stars$57.23+1.0%$118.33+106.8%-39.8%$1.34B$2.20B6.86950News CoverageSDHCSmith Douglas Homes1.9657 of 5 stars$18.40-1.9%$24.60+33.7%-24.7%$943.59M$975.46M10.45364Short Interest ↑News Coverage Related Companies and Tools Related Companies TMHC Competitors IBP Competitors ROAD Competitors IESC Competitors GRBK Competitors DFH Competitors BBU Competitors CCS Competitors LGIH Competitors SDHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ECG) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Everus Please log in to your account or sign up in order to add this asset to your watchlist. Share Everus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ECG Stock Free ECG Stock Alerts